Beijing Friendship Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1952-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- https://www.bfh.com.cn
Effect of Covid-19 Epidemic on Primary PCI in Patients With STEMI
- Conditions
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2020-06-11
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT04427735
- Locations
- 🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, China
Status of Management of Surgery in Beijing During COVID-19
- Conditions
- Interventions
- First Posted Date
- 2020-05-26
- Last Posted Date
- 2020-05-27
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT04401124
Effectiveness of Bariatric Surgery for NAFLD/NASH
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-04-29
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 320
- Registration Number
- NCT04366999
- Locations
- 🇨🇳
Beijing Friendship Hospital, Beijing, Beijing, China
Efficacy and Safety of Camrelizumab for Injection, Apatinib Mesylate and Tegio for First-line Refractory Patients With Advanced Gastric Cancer
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2020-04-14
- Last Posted Date
- 2020-04-14
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT04345783
- Locations
- 🇨🇳
Beijing Friendship Hospital, Beijing, Beijing, China
Efficacy and Safety of Apatinib Combined With S-1 for Patients With Advance Gastric Cancer
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-04-08
- Last Posted Date
- 2020-11-10
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 37
- Registration Number
- NCT04338438
Effect of CI on Prognosis in the Elderly Patients With ACS
- Conditions
- Interventions
- First Posted Date
- 2020-02-20
- Last Posted Date
- 2020-02-20
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT04278911
- Locations
- 🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
Neoadjuvant Chomotherapy With Paclitaxel-albumin and S-1 for Advanced Gastric Cancer
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2020-02-06
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT04258657
- Locations
- 🇨🇳
Zhongtao Zhang, Beijing, Beijing, China
Camrelizumab in Combination With Apatinib Mesylate, Paclitaxel-albumin and S-1 for Translational Treatment of Gastric Cancer
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2020-02-06
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT04258644
- Locations
- 🇨🇳
Beijing Friendship Hospital, Beijing, Beijing, China
Ruxolitinib as a Salvage Therapy for Hemophagocytic Lymphohistiocytosis
Phase 3
- Conditions
- Interventions
- First Posted Date
- 2019-10-09
- Last Posted Date
- 2019-10-29
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT04120090
- Locations
- 🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
PD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBV
- First Posted Date
- 2019-09-10
- Last Posted Date
- 2022-01-05
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT04084626
- Locations
- 🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
© Copyright 2024. All Rights Reserved by MedPath